Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging

[1]  T. Mikkelsen,et al.  Imaging response criteria for recurrent gliomas treated with bevacizumab: Role of diffusion weighted imaging as an imaging biomarker , 2010, Journal of Neuro-Oncology.

[2]  P. Sundgren.  MR Spectroscopy in Radiation Injury , 2009, American Journal of Neuroradiology.

[3]  P. Wen,et al.  A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients. , 2009, Cancer research.

[4]  Matthew S. Brown,et al.  Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment. , 2009, Radiology.

[5]  Timothy D Johnson,et al.  The parametric response map is an imaging biomarker for early cancer treatment outcome , 2009, Nature Medicine.

[6]  Susan Chang,et al.  Pseudoprogression and pseudoresponse: Challenges in brain tumor imaging , 2009, Current neurology and neuroscience reports.

[7]  Janet F. Eary,et al.  NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of 3′-Deoxy-3′-[18F]fluorothymidine (FLT) as a Marker of Proliferation in Patients with Recurrent Gliomas: Preliminary Efficacy Studies , 2009, Molecular Imaging and Biology.

[8]  P. Sundgren,et al.  Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions. , 2009, AJR. American journal of roentgenology.

[9]  T. Mikkelsen,et al.  Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan , 2009, Journal of Neuro-Oncology.

[10]  M R Segal,et al.  Distinguishing Recurrent Intra-Axial Metastatic Tumor from Radiation Necrosis Following Gamma Knife Radiosurgery Using Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging , 2008, American Journal of Neuroradiology.

[11]  P. Wen,et al.  Response criteria for glioma , 2008, Nature Clinical Practice Oncology.

[12]  P. Kelly,et al.  High-grade glioma before and after treatment with radiation and Avastin: initial observations. , 2008, Neuro-oncology.

[13]  Timothy D Johnson,et al.  Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Douglas C. Miller,et al.  Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. , 2008, Radiology.

[15]  T. Mikkelsen,et al.  Quantitative Estimation of Permeability Surface-Area Product in Astroglial Brain Tumors Using Perfusion CT and Correlation with Histopathologic Grade , 2008, American Journal of Neuroradiology.

[16]  Yue Cao,et al.  Radiation-induced changes in normal-appearing white matter in patients with cerebral tumors: a diffusion tensor imaging study. , 2008, International journal of radiation oncology, biology, physics.

[17]  J. Henson,et al.  Brain Tumor Imaging in Clinical Trials , 2008, American Journal of Neuroradiology.

[18]  T. Mikkelsen,et al.  Role of Perfusion CT in Glioma Grading and Comparison with Conventional MR Imaging Features , 2007, American Journal of Neuroradiology.

[19]  T. Mikkelsen,et al.  FIRST‐PASS PERFUSION COMPUTED TOMOGRAPHY: INITIAL EXPERIENCE IN DIFFERENTIATING RECURRENT BRAIN TUMORS FROM RADIATION EFFECTS AND RADIATION NECROSIS , 2007, Neurosurgery.

[20]  Ricky T. Tong,et al.  Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. , 2007, Cancer research.

[21]  Andrew E. Sloan,et al.  Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma , 2007, Journal of Neuro-Oncology.

[22]  Takashi Inoue,et al.  Diffusion tensor imaging for differentiation of recurrent brain tumor and radiation necrosis after radiotherapy—Three case reports , 2007, Clinical Neurology and Neurosurgery.

[23]  Thomas L Chenevert,et al.  Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions. , 2006, Magnetic resonance imaging.

[24]  Wei Chen,et al.  18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  Bradford A Moffat,et al.  The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. , 2006, Neoplasia.

[26]  Juergen Hennig,et al.  Quantitative diffusion tensor MR imaging of the brain: field strength related variance of apparent diffusion coefficient (ADC) and fractional anisotropy (FA) scalars , 2006, European Radiology.

[27]  Glyn Johnson,et al.  Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response. , 2006, Radiology.

[28]  B. Nan,et al.  Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. , 2005, AJR. American journal of roentgenology.

[29]  Mark E Mullins,et al.  Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis. , 2005, AJNR. American journal of neuroradiology.

[30]  Toshinori Hirai,et al.  Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. , 2005, AJNR. American journal of neuroradiology.

[31]  T. Kaminaga,et al.  Radiation-Induced Brain Metabolic Changes in the Acute and Early Delayed Phase Detected With Quantitative Proton Magnetic Resonance Spectroscopy , 2005, Journal of computer assisted tomography.

[32]  Hiroyuki Kabasawa,et al.  Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas , 2005, Clinical Neurology and Neurosurgery.

[33]  Jae Seung Kim,et al.  [18F]3′-deoxy-3′-fluorothymidine PET for the diagnosis and grading of brain tumors , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  Yukihiko Fujii,et al.  Diffusion tensor analysis of peritumoral edema using lambda chart analysis indicative of the heterogeneity of the microstructure within edema. , 2005, Journal of neurosurgery.

[35]  Khader M Hasan,et al.  Diffusion tensor eigenvector directional color imaging patterns in the evaluation of cerebral white matter tracts altered by tumor , 2004, Journal of magnetic resonance imaging : JMRI.

[36]  Michael H Lev,et al.  Dynamic magnetic resonance perfusion imaging of brain tumors. , 2004, The oncologist.

[37]  J. Hopewell,et al.  Experimental evidence to support the hypothesis that damage to vascular endothelium plays the primary role in the development of late radiation-induced CNS injury. , 2004, The British journal of radiology.

[38]  T. Mikkelsen,et al.  Associations among Magnetic Resonance Spectroscopy, Apparent Diffusion Coefficients, and Image-Guided Histopathology with Special Attention to Radiation Necrosis , 2004, Neurosurgery.

[39]  Glyn Johnson,et al.  Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. , 2004, AJNR. American journal of neuroradiology.

[40]  C. Eskey,et al.  Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. , 2004, AJNR. American journal of neuroradiology.

[41]  K. Ohata,et al.  Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? , 2003, Journal of neurosurgery.

[42]  N. Newman,et al.  Diffusion weighted imaging in radiation necrosis , 2003, Journal of neurology, neurosurgery, and psychiatry.

[43]  R. Jain.  Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. , 2002, Seminars in oncology.

[44]  E. A. Chiocca,et al.  In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. , 2002, Radiology.

[45]  James M Provenzale,et al.  Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. , 2002, Radiology.

[46]  Mark E Bastin,et al.  Diffusion tensor MR imaging of high-grade cerebral gliomas. , 2002, AJNR. American journal of neuroradiology.

[47]  G. van Kaick,et al.  Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy , 2002, Neuroradiology.

[48]  O. Witte,et al.  Positron emission tomography with injection of methionine as a prognostic factor in glioma. , 2001, Journal of neurosurgery.

[49]  M. Westphal,et al.  Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. , 2001, Cancer research.

[50]  Rakesh K. Jain,et al.  Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy , 2001, Nature Medicine.

[51]  G. Tung,et al.  Diffusion-weighted MR imaging of rim-enhancing brain masses: is markedly decreased water diffusion specific for brain abscess? , 2001, AJR. American journal of roentgenology.

[52]  P Bachert,et al.  Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. , 2001, AJNR. American journal of neuroradiology.

[53]  M. Lopes,et al.  Radiosurgery-induced Microvascular Alterations Precede Necrosis of the Brain Neuropil , 2001, Neurosurgery.

[54]  G. Barnett,et al.  The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery , 2001, International journal of cancer.

[55]  J. M. Taylor,et al.  Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. , 2000, Journal of the National Cancer Institute.

[56]  M. Westphal,et al.  Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. , 2000, Neoplasia.

[57]  M Takahashi,et al.  Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. , 2000, AJNR. American journal of neuroradiology.

[58]  V. Chong,et al.  Temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma: 1H MR spectroscopic findings. , 1999, International journal of radiation oncology, biology, physics.

[59]  G. Yancopoulos,et al.  Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.

[60]  P. V. van Rijk,et al.  Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study. , 1999, Nuclear medicine communications.

[61]  T. Cloughesy,et al.  Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma , 1999, Magnetic resonance in medicine.

[62]  Toshinori Hirai,et al.  Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.

[63]  J. Le Bas,et al.  Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy. , 1998, International journal of radiation oncology, biology, physics.

[64]  P. Batchelor,et al.  International Society for Magnetic Resonance in Medicine , 1997 .

[65]  W. Dillon,et al.  Radiation-induced telangiectasia in the brain simulates cryptic vascular malformations at MR imaging. , 1994, Radiology.

[66]  R D Tien,et al.  MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. , 1994, AJR. American journal of roentgenology.

[67]  K. Frey,et al.  Discordance Between F‐18 Fluorodeoxyglucose Uptake and Contrast Enhancement in a Brain Abscess , 1993, Clinical nuclear medicine.

[68]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[69]  Georg Breier,et al.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.

[70]  A. Alavi,et al.  New grading system of cerebral gliomas using positron emisson tomography with F-18 fluorodeoxyglucose , 1991, Journal of Neuro-Oncology.

[71]  R. G. Manning,et al.  Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. , 1982, Radiology.

[72]  V. Chong,et al.  Temporal lobe changes following radiation therapy: imaging and proton MR spectroscopic findings , 2001, European Radiology.

[73]  J K Smith,et al.  Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. , 2001, AJNR. American journal of neuroradiology.

[74]  A. J. Kumar,et al.  Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. , 2000, Radiology.

[75]  M. Castillo,et al.  Clinical applications of proton MR spectroscopy. , 1996, AJNR. American journal of neuroradiology.

[76]  P. Basser,et al.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. , 1996, Journal of magnetic resonance. Series B.

[77]  Robert Turner,et al.  Diffusion and perfusion magnetic resonance imaging in brain tumors , 1993, Topics in magnetic resonance imaging : TMRI.